We are live on ! Find out more
BCAB icon

BioAtla
BCAB

79 hedge funds and large institutions have $71.3M invested in BioAtla in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 27 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

750% more call options, than puts

Call options by funds: $119K | Put options by funds: $14K

39% more capital invested

Capital invested by funds: $51.3M → $71.3M (+$19.9M)

0.05% less ownership

Funds ownership: 1.26% → 1.21% (-0.05%)

4% less funds holding

Funds holding: 82 → 79 (-3)

11% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 27

18% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 17

Holders
79
Holders Change
-3
Holders Change %
-3.66%
% of All Funds
1.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
24
Reduced
27
Closed
17
Calls
$119K
Puts
$14K
Net Calls
+$105K
Net Calls Change
+$3K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$3.86M
2
Deutsche Bank
Deutsche Bank
Germany
+$1.47M
3
Renaissance Technologies
Renaissance Technologies
New York
+$628K
4
MA
MYDA Advisors
New York
+$312K
5
Millennium Management
Millennium Management
New York
+$218K

Top Sellers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
-$2.17M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$2.07M
3
O
OrbiMed
New York
-$1.72M
4
VC
Vivo Capital
California
-$908K
5
WA
Wasatch Advisors
Utah
-$840K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Soleus Capital Management
Connecticut
$10M -$505K -5,820 -7%
Morgan Stanley
2
Morgan Stanley
New York
$9.41M +$3.86M +44,509 +139%
BlackRock
3
BlackRock
New York
$7.09M -$398K -4,588 -7%
TCM
4
Tang Capital Management
California
$6.21M -$2.17M -25,086 -33%
Vanguard Group
5
Vanguard Group
Pennsylvania
$5.12M -$36.3K -419 -1%
CAM
6
Cormorant Asset Management
Massachusetts
$2.91M – – –
Deutsche Bank
7
Deutsche Bank
Germany
$2.77M +$1.47M +16,922 +303%
Renaissance Technologies
8
Renaissance Technologies
New York
$2.43M +$628K +7,246 +58%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$2.22M +$90.2K +1,040 +6%
State Street
10
State Street
Massachusetts
$1.78M – – –
Vontobel Holding
11
Vontobel Holding
Switzerland
$1.74M -$15.9K -183 -1%
SAM
12
Sectoral Asset Management
Quebec, Canada
$1.74M – – –
BC
13
Boxer Capital
California
$1.69M – – –
Adage Capital Partners
14
Adage Capital Partners
Massachusetts
$1.48M -$2.07M -23,923 -67%
Massachusetts Financial Services
15
Massachusetts Financial Services
Massachusetts
$1.3M +$867 +10 +0.1%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
16
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$1.26M – – –
Norges Bank
17
Norges Bank
Norway
$1.2M – – –
Northern Trust
18
Northern Trust
Illinois
$875K -$2.51K -29 -0.4%
Bank of Montreal
19
Bank of Montreal
Ontario, Canada
$866K +$141K +1,632 +37%
Two Sigma Advisers
20
Two Sigma Advisers
New York
$642K +$7.28K +84 +2%
MA
21
MYDA Advisors
New York
$541K +$312K +3,600 +450%
Millennium Management
22
Millennium Management
New York
$538K +$218K +2,519 +136%
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$518K -$84K -969 -19%
UOC
24
UBS O'Connor
Illinois
$444K -$455K -5,246 -59%
N
25
Nuveen
North Carolina
$438K +$10.4K +120 +3%
1
2 3 4

BCAB Hedge Fund Activity: Q4 2023 in Review

79 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in BioAtla (BCAB) for Q4 2023, worth a combined $71.3M — up 39% from $51.3M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of BCAB and 14 opened new positions — a net loss of 3 holders — while 27 trimmed existing stakes and 24 added.

The largest buyer was Morgan Stanley, adding an estimated $3.86M. The largest seller was Tang Capital Management, cutting an estimated $2.17M.

  • 79 institutional investors held BioAtla (BCAB) as of Q4 2023, down from 82 in Q3 2023.
  • Funds reported $71.3M of BioAtla stock for Q4 2023, up 39% quarter-over-quarter.
  • 14 funds opened new BioAtla positions in Q4 2023 and 17 closed out, a net change of -3 holders.
  • The largest BioAtla buyer in Q4 2023 was Morgan Stanley, an estimated $3.86M added.
  • The largest BioAtla seller in Q4 2023 was Tang Capital Management, an estimated $2.17M sold.

Based on aggregated 13F filings for Q4 2023.